Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › L-.beta.-dioxolane uridine analog administration for treating Epstein-Barr virus infection

L-.beta.-dioxolane uridine analog administration for treating Epstein-Barr virus infection

US Patent 5792773 · Granted Aug 11, 1998

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Herbal composition PHY906 and its use in chemotherapy2025
Herbal composition PHY906 and its use in chemotherapy2024
Prodrugs of L-BHDU and methods of treating viral infections2024
Mechanism based quality control for botanical medicine2024
Inhibition of androgen receptor by extracts of medicinal herbs and compositions 2023
Herbal composition PHY906 and its use in chemotherapy2023
Glucagon-like peptide1 receptor agonists2023
Use of PHY906 as treatment for inflammatory bowel disease and/or irritable bowel2022
Herbal composition PHY906 and its use in chemotherapy2022
2′-fluoro-6′-methylene carbocyclic nucleosides and methods of treating viral inf2021
Synthesis of 2′-fluoro-6′-methylene-carbocyclic adenosine (FMCA) and 2′-fluoro-62021
Use of PHY906 as treatment for inflammatory bowel disease and/or irritable bowel2020